Skip to main content

Now live! Explore the program for the upcoming 2024 Global Conference, taking place May 5-8, 2024.

Type 1 Diabetes Autoantibody Screening Implementation Roadmap: 2022 REPORT UPDATE

In April 2021, the Milken Institute, with generous funding from the Leona M. and Harry B. Helmsley Charitable Trust, published a report focused on the implementation of type 1 diabetes (T1D) autoantibody screening in the general population.

The field has moved quickly and, as such, the Center for Strategic Philanthropy (CSP) undertook extensive follow-up research to provide an update highlighting the state of progress toward accessible screenings for all.

For this update, CSP interviewed 27 thought leaders and stakeholders, opened a public comment period, and hosted a public session to discuss the status of the goals and action items in the roadmap. Based on input from the field, this report update captures the ongoing efforts of the community to continue toward T1D screening for the general population and identifies areas where further work or collaboration might be needed.

The original report, published on April 5, 2021, can be found here.